Nektar Therapeutics
NKTR
#4850
Rank
S$2.60 B
Marketcap
S$77.07
Share price
-1.90%
Change (1 day)
586.84%
Change (1 year)

Nektar Therapeutics (NKTR) - Total assets

Total assets on the balance sheet as of March 2026 : S$0.98 Billion

According to Nektar Therapeutics 's latest financial reports the company's total assets are S$0.98 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Nektar Therapeutics - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31S$0.36 B-12.83%
2024-12-31S$0.41 B-21.43%
2023-12-31S$0.52 B-44.82%
2022-12-31S$0.95 B-36.93%
2021-12-31S$1.51 B-25.81%
2020-12-31S$2.03 B-23.64%
2019-12-31S$2.66 B-9.25%
2018-12-31S$2.93 B331.59%
2017-12-31S$0.68 B-17.33%
2016-12-31S$0.82 B16.73%
2015-12-31S$0.70 B20.88%
2014-12-31S$0.58 B5.99%
2013-12-31S$0.55 B-9.56%
2012-12-31S$0.60 B-22.5%
2011-12-31S$0.78 B17%
2010-12-31S$0.67 B-16.9%
2009-12-31S$0.80 B0.79%
2008-12-31S$0.80 B-23.17%
2007-12-31S$1.04 B-11.42%
2006-12-31S$1.17 B-17.6%
2005-12-31S$1.42 B17.63%
2004-12-31S$1.21 B15.97%
2003-12-31S$1.04 B-0.45%
2002-12-31S$1.05 B-14.78%
2001-12-31S$1.23 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
S$259.04 B 26,220.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$267.71 B 27,101.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$119.28 B 12,019.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$25.59 B 2,500.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$165.93 B 16,759.67%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$147.02 B 14,837.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
S$0.26 B-73.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$5.49 B 457.87%๐Ÿ‡ฎ๐Ÿ‡ช Ireland